10.6002/ect.2024.0085
-
Published:2024-07
Issue:7
Volume:22
Page:
-
ISSN:1304-0855
-
Container-title:Experimental and Clinical Transplantation
-
language:
-
Short-container-title:Exp Clin Transplant
Publisher
Baskent University
Reference34 articles.
1. 1. Liu JZ, Hov JR, Folseraas T, et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet. 2013;45(6):670-675. doi:10.1038/ng.2616 2. 2. Ellinghaus D, Jostins L, Spain SL, et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet. 2016;48(5):510-518. doi:10.1038/ng.3528 3. 3. Ji SG, Juran BD, Mucha S, et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat Genet. 2017;49(2):269-273. doi:10.1038/ng.3745 4. 4. Boonstra K, van Erpecum KJ, van Nieuwkerk KM, et al. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(12):2270-2276. doi:10.1002/ibd.22938 5. 5. LaRusso NF, Shneider BL, Black D, et al. Primary sclerosing cholangitis: summary of a workshop. Hepatology. 2006;44(3):746-764. doi:10.1002/hep.21337
|
|